These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9253199)
41. Variation in photodynamic efficacy during the cellular uptake of two phthalocyanine photosensitizers. He J; Horng MF; Deahl JT; Oleinick NL; Evans HH Photochem Photobiol; 1998 Jun; 67(6):720-8. PubMed ID: 9648537 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy. Asano R; Nagami A; Fukumoto Y; Yazama F; Ito H; Sakata I; Tai A Bioorg Med Chem; 2013 Apr; 21(8):2298-2304. PubMed ID: 23477944 [TBL] [Abstract][Full Text] [Related]
43. [Spectral properties of new photosensitizers for photodynamic diagnosis and therapy]. Li BH; Xie SS; Lu ZK Guang Pu Xue Yu Guang Pu Fen Xi; 2002 Dec; 22(6):902-4. PubMed ID: 12914159 [TBL] [Abstract][Full Text] [Related]
44. Ex vivo quantification of mTHPC concentration in tissue: influence of chemical extraction on the optical properties. Kascáková S; Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Robinson DJ; Sterenborg HJ; Amelink A J Photochem Photobiol B; 2008 May; 91(2-3):99-107. PubMed ID: 18359242 [TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. Gupta S; Dwarakanath BS; Chaudhury NK; Mishra AK; Muralidhar K; Jain V J Cancer Res Ther; 2011; 7(3):314-24. PubMed ID: 22044814 [TBL] [Abstract][Full Text] [Related]
46. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer. Kuzyniak W; Schmidt J; Glac W; Berkholz J; Steinemann G; Hoffmann B; Ermilov EA; Gürek AG; Ahsen V; Nitzsche B; Höpfner M Int J Oncol; 2017 Mar; 50(3):953-963. PubMed ID: 28098886 [TBL] [Abstract][Full Text] [Related]
47. Development and biodistribution of a theranostic aluminum phthalocyanine nanophotosensitizer. Asem H; El-Fattah AA; Nafee N; Zhao Y; Khalil L; Muhammed M; Hassan M; Kandil S Photodiagnosis Photodyn Ther; 2016 Mar; 13():48-57. PubMed ID: 26708297 [TBL] [Abstract][Full Text] [Related]
48. Hydroporphyrins as tumour photosensitizers: synthesis and photophysical studies of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin. Ferrand Y; Bourré L; Simonneaux G; Thibaut S; Odobel F; Lajat Y; Patrice T Bioorg Med Chem Lett; 2003 Mar; 13(5):833-5. PubMed ID: 12617902 [TBL] [Abstract][Full Text] [Related]
49. Spectroscopic and biological testing of photobleaching of porphyrins in solutions. Bezdetnaya L; Zeghari N; Belitchenko I; Barberi-Heyob M; Merlin JL; Potapenko A; Guillemin F Photochem Photobiol; 1996 Aug; 64(2):382-6. PubMed ID: 8760578 [TBL] [Abstract][Full Text] [Related]
50. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization. Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437 [TBL] [Abstract][Full Text] [Related]
51. Structure and biodistribution relationships of photodynamic sensitizers. Boyle RW; Dolphin D Photochem Photobiol; 1996 Sep; 64(3):469-85. PubMed ID: 8806226 [TBL] [Abstract][Full Text] [Related]
52. Biological activities of phthalocyanines--XV. Radiolabeling of the differently sulfonated 67Ga-phthalocyanines for photodynamic therapy and tumor imaging. Scasnár V; van Lier JE Nucl Med Biol; 1993 Apr; 20(3):257-62. PubMed ID: 8485484 [TBL] [Abstract][Full Text] [Related]
53. Photodynamic therapy and some clinical applications in oncology. Dima VF; Ionescu MD; Balotescu C; Dima SF Roum Arch Microbiol Immunol; 2002; 61(3):159-205. PubMed ID: 14752983 [TBL] [Abstract][Full Text] [Related]
54. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Zenzen V; Zankl H Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024 [TBL] [Abstract][Full Text] [Related]
56. Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors. Sheng C; Pogue BW; Wang E; Hutchins JE; Hoopes PJ Photochem Photobiol; 2004 Jun; 79(6):520-5. PubMed ID: 15291303 [TBL] [Abstract][Full Text] [Related]
57. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge. Ball DJ; Mayhew S; Wood SR; Griffiths J; Vernon DI; Brown SB Photochem Photobiol; 1999 Mar; 69(3):390-6. PubMed ID: 10232957 [TBL] [Abstract][Full Text] [Related]
58. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy. Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568 [TBL] [Abstract][Full Text] [Related]
59. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Brasseur N; Ouellet R; La Madeleine C; van Lier JE Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394 [TBL] [Abstract][Full Text] [Related]
60. Raman microspectroscopy of Hematoporphyrins. Imaging of the noncancerous and the cancerous human breast tissues with photosensitizers. Brozek-Pluska B; Kopec M Spectrochim Acta A Mol Biomol Spectrosc; 2016 Dec; 169():182-91. PubMed ID: 27376758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]